EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Anti-Arthritic Effect of Edaravone Against Complete Freund Adjuvant Induced Arthritis via Osteoclast Differentiation and HIF-1α–VEGF–ANG-1 Axis

Jichao Liu, Nan Zhao, Shi-Han Su, Yun Gao, Bo Qi

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s391606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Jichao Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hand and Foot Micro Burn Plastic Surgery, 3201 Hospital, Hanzhong, People's Republic of China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Arthritis, Experimental. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bone dysfunction is a crucial problem that occurs during rheumatoid arthritis (RA) disease. Osteoclast plays a significant role in bone resorption and osteoclast differentiation and its enhancement of bone destruction. Edaravone remarkably exhibited free radical scavenging and anti-inflammatory effects. The objective of the current investigation is to comfort the inhibitory effect of Edaravone (ED) against complete Freund adjuvant (CFA) rat model via inhibition of angiogenesis and inflammation.

Methods

Subcutaneous injection of CFA (1%) was used to induce arthritis; the rats were divided into different groups and received the oral administration of ED. Paw edema, body weight, and arthritis score were regularly estimated. Biochemical parameters were estimated, respectively. We also estimate the level of hypoxia-inducible factor-1α (HIF-1α), angiopoietin 1 (ANG-1), and vascular endothelial growth factor (VEGF). We also checked into how ED affected the differentiation of osteoclasts utilising a co-culture system with monocytes and synovial fibroblasts in arthritis rats.

Results

ED treatment significantly (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidArthritis, ExperimentalRatsMiceAnimalsOsteoclastsVascular Endothelial Growth Factor AFreund's AdjuvantEdaravoneAngiopoietin-1Hypoxia-Inducible Factor 1, alpha SubunitCytokines

Stichwörter der Autor:innen

Edaravoneangiogenesisarthritisinflammationosteoclast differentiationoxidative stress

Substanzen

Vascular Endothelial Growth Factor AFreund's AdjuvantEdaravoneAngiopoietin-1Hypoxia-Inducible Factor 1, alpha SubunitCytokines

Autor:innen und Institutionen

  • Department of Hand and Foot Micro Burn Plastic Surgery, 3201 Hospital, Hanzhong, People's Republic of China.
  • Department of Neurosurgery, The First Hospital of Kunming, Kunming, People's Republic of China.
  • Department of Internal Medicine-Neurology, 920th Hospital of Joint Logistics Support Force, Kunming, People's Republic of China.
  • Department of Orthopaedics, 920th Hospital of Joint Logistics Support Force, Kunming, People's Republic of China.

Zitieren

APA

Liu, J., Zhao, N., Su, S. H., Gao, Y., & Qi, B. (2023). Anti-Arthritic Effect of Edaravone Against Complete Freund Adjuvant Induced Arthritis via Osteoclast Differentiation and HIF-1α–VEGF–ANG-1 Axis. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s391606

Vancouver

Liu J, Zhao N, Su SH, Gao Y, Qi B. Anti-Arthritic Effect of Edaravone Against Complete Freund Adjuvant Induced Arthritis via Osteoclast Differentiation and HIF-1α–VEGF–ANG-1 Axis. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s391606

BibTeX
@article{Liu2023,
  author = {Liu, Jichao and Zhao, Nan and Su, Shi-Han and Gao, Yun and Qi, Bo},
  title = {Anti-Arthritic Effect of Edaravone Against Complete Freund Adjuvant Induced Arthritis via Osteoclast Differentiation and HIF-1α–VEGF–ANG-1 Axis},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s391606}
}
Kostenlos starten →